External Publications
Is It Time to Reconsider the Role of Co-Payments in Europe?
11 January 2012
In a recent editorial in the European Journal of Health Economics, Prof Michael Drummond of York University and Prof Adrian Towse of the OHE take a…
Can and Should Value Based Pricing Be Applied to Molecular Diagnostics?
1 April 2012
Diagnostics not only facilitate health gain and cost savings, but also provide information to inform patients’ decisions on interventions and to clarify how their behaviour may…
New Insights into Hospital Efficiency: Linking Costs and Patient Outcomes
18 October 2011
A new discussion paper from the Centre of Health Economics (CHE), University of York, reports first results from a programme of collaborative research by CHE, Nancy…
Evidence on Valued Based Pricing and Reimbursement Schemes
30 September 2011
At the PPRI conference in Vienna on 29-30 September, 2011, Jorge Mestre-Ferrandiz presented a poster summarising the results of a literature review on risk sharing, flexible…
HTA and Appropriate Drug Pricing Worldwide
9 September 2011
The August 2011 issue of Health Affairs featured four articles on how and why pricing for pharmaceuticals differs from one country to another. The OHE’s Prof…
Incentives for R&D for New Antimicrobial Drugs
31 August 2011
Just published by OHE researchers is a comprehensive analysis of what policy measures are needed to counter the growing global problem of antimicrobial resistance. Their key…
Pricing in Emerging Markets: Income, Competition and Procurement
16 August 2011
Most patients in middle and low income countries (MLICs) lack insurance coverage and so pay out of pocket for prescription medicines; pricing commensurate with income thus…
Drugs and Vaccines for Developing Countries
1 June 2011
Forthcoming in the Oxford Handbook on the Economics of the Biopharmaceutical Industry, this paper describes the context of the problem of access to medicines in developing…
Measuring Value with Pharmacoeconomics
26 May 2011
In forthcoming chapter in the Oxford Handbook on the Economics of the Biopharmaceutical Industry, experts in the field outline the evolution of cost-effectiveness analysis (CEA) through…